Volume 26, Number 4—April 2020
Synopsis
High Incidence of Active Tuberculosis in Asylum Seekers from Eritrea and Somalia in the First 5 Years after Arrival in the Netherlands
Table 1
Characteristic | Total study population | Country of origin |
p value† | |
---|---|---|---|---|
Eritrea | Somalia | |||
Population size, no. |
26,057 |
21,182 |
4,875 |
NA |
Arrivals per year | ||||
2013 | 3,741 (14.4) | 911 (4.3) | 2,830 (58.1) | <0.001 |
2014 | 5,353 (20.5) | 4,168 (19.7) | 1,185 (24.3) | <0.001 |
2015 | 8,889 (34.1) | 8,378 (39.6) | 511 (10.5) | <0.001 |
2016 | 3,484 (13.4) | 3,250 (15.3) | 234 (4.8) | <0.001 |
2017 |
4.590 (17.6) |
4,475 (21.1) |
115 (2.4) |
<0.001 |
Age group | ||||
<18 y | 10,750 (41.3) | 7,320 (34.6) | 3,430 (70.4) | <0.001 |
>18 y |
15,307 (58.7) |
13,862 (65.4) |
1,445 (29.6) |
<0.001 |
Sex | ||||
F | 10,731 (41.2) | 8,191 (38.7) | 2,520 (51.7) | <0.001 |
M |
15,326 (58.8) |
12,991 (61.3) |
2,355 (48.3) |
<0.001 |
Persons with prevalent TB | 78 (0.3) | 61 (0.3) | 17 (0.4) | 0.48 |
Of whom had PTB |
59/78 (75.6) |
49/61 (80.3) |
10/17 (62.5) |
0.068 |
Persons with incident TB | 468 (1.8) | 338 (1.6) | 130 (2.7) | <0.001‡ |
Of whom had PTB | 238/468 (50.9) | 181/338 (53.6) | 57/130 (43.5) | 0.060 |
Detected in follow-up screening | 77/468 (16.5) | 67/338 (19.8) | 10/130 (7.6) | 0.002 |
*Values are no. (%) unless indicated. NA, not applicable; PTB, pulmonary tuberculosis; TB, tuberculosis.
†Case-patients from Eritrea compared with those from Somalia.
‡Proportion of incident cases cannot truly be compared between case-patients from Eritrea and those from Somalia because follow-up time was different (median of 28 months for case-patients from Eritrea versus 49 months for those from Somalia).
Page created: March 17, 2020
Page updated: March 17, 2020
Page reviewed: March 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.